About the Authors
- Mingyu Liu
-
* E-mail: Grant.walkup@astrazeneca.com (GKW); Mingyu-mandy.liu@astrazeneca.com (ML)
Affiliation Biology Department, Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, Massachusetts, United States of America
- Christina Blinn
-
Affiliation Biology Department, Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, Massachusetts, United States of America
- Sarah M. McLeod
-
Affiliation Biology Department, Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, Massachusetts, United States of America
- John W. Wiseman
-
Affiliation RAD-Transgenics, Discovery Sciences, AstraZeneca R&D Mölndal, Mölndal, Sweden
- Joseph V. Newman
-
Affiliation Biology Department, Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, Massachusetts, United States of America
- Stewart L. Fisher
-
Affiliation Biology Department, Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, Massachusetts, United States of America
- Grant K. Walkup
-
* E-mail: Grant.walkup@astrazeneca.com (GKW); Mingyu-mandy.liu@astrazeneca.com (ML)
Affiliation Biology Department, Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, Massachusetts, United States of America
Competing Interests
All authors declare the competing financial interest of employment by AstraZeneca. In addition, authors SMM, JWW, JVN, SLF, and GKW own stock and/or stock options of AstraZeneca. However, this statement does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ML SMM JVN SLF GKW. Performed the experiments: ML CB JWW SMM. Analyzed the data: ML GKW. Wrote the paper: ML SMM SLF GKW.